BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1390333)

  • 21. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
    Veltri EP; Reid PR; Platia EV; Griffith LS
    Am J Cardiol; 1985 Feb; 55(4):375-9. PubMed ID: 3969872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial ischemia and induction of sustained ventricular tachyarrhythmias: evaluation using dobutamine stress echocardiography-electrophysiologic testing.
    Stambler BS; Akosah KO; Mohanty PK; Wood MA; Ellenbogen KA
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):901-7. PubMed ID: 15333083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Encainide in lethal ventricular arrhythmias evaluated by electrophysiologic testing and decrease in symptoms.
    Horowitz LN
    Am J Cardiol; 1986 Aug; 58(5):83C-86C. PubMed ID: 3092624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meobentine sulfate: antiarrhythmic and electrophysiologic effects assessed by programmed electrical stimulation and ambulatory monitoring in patients with complex ventricular tachyarrhythmia. Report of a multicenter evaluation.
    Anderson JL; Reid PR; Platia EV; Akhtar M; Ruskin JN; Schaal SF; Jueng P; Long RA; Wenger TL
    Am Heart J; 1985 Oct; 110(4):774-84. PubMed ID: 3901715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective, randomized comparison of conventional and high dose loading regimens of amiodarone in the treatment of ventricular tachycardia.
    Kalbfleisch SJ; Williamson B; Man KC; Vorperian V; Hummel JD; Hasse C; Strickberger SA; Calkins H; Langberg JJ; Morady F
    J Am Coll Cardiol; 1993 Nov; 22(6):1723-9. PubMed ID: 8227846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing the yield of ventricular tachycardia induction: a prospective, randomized comparative study of the standard ventricular stimulation protocol to a short-to-long protocol and a new two-site protocol.
    Simonson JS; Gang ES; Mandel W; Peter T
    Am Heart J; 1991 Jan; 121(1 Pt 1):68-76. PubMed ID: 1985380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of successful suppression of sustained ventricular tachyarrhythmias by serial drug testing from data derived at the initial electrophysiologic study.
    Kuchar DL; Rottman J; Berger E; Freeman CS; Garan H; Ruskin JN
    J Am Coll Cardiol; 1988 Oct; 12(4):982-8. PubMed ID: 3047198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiologic characteristics of ventricular tachycardia or fibrillation in relation to age of myocardial infarction.
    Stevenson WG; Brugada P; Kersschot I; Waldecker B; Zehender M; Geibel A; Wellens HJ
    Am J Cardiol; 1986 Feb; 57(6):387-91. PubMed ID: 3946252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term efficacy and safety of beta-adrenergic receptor antagonists for supraventricular tachycardia.
    Lindsay BD; Saksena S; Rothbart ST; Herman S; Barr MJ
    Am J Cardiol; 1987 Aug; 60(6):63D-67D. PubMed ID: 2888301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of oral sotalol for sustained ventricular tachyarrhythmias refractory to other antiarrhythmic agents.
    Kehoe RF; MacNeil DJ; Zheutlin TA; Ezri MD; Nazari J; Spangenberg RB; Dunnington C; Lueken M
    Am J Cardiol; 1993 Aug; 72(4):56A-66A. PubMed ID: 8346728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disopyramide: evaluation of electrophysiologic effects and clinical efficacy in patients with sustained ventricular tachycardia or ventricular fibrillation.
    Lerman BB; Waxman HL; Buxton AE; Josephson ME
    Am J Cardiol; 1983 Mar; 51(5):759-64. PubMed ID: 6829435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of nadolol alone or in combination with a type IA antiarrhythmic drug in sustained ventricular tachycardia: a prospective study.
    Munsif AN; Saksena S
    Pacing Clin Electrophysiol; 1989 Nov; 12(11):1816-26. PubMed ID: 2478982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amiodarone therapy for sustained ventricular tachycardia after myocardial infarction: long-term follow-up, risk assessment and predictive value of programmed ventricular stimulation.
    Maury P; Zimmermann M; Metzger J; Reynard C; Dorsaz P; Adamec R
    Int J Cardiol; 2000; 76(2-3):199-210. PubMed ID: 11104875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paired comparisons of efficacy of intravenous and oral procainamide in patients with inducible sustained ventricular tachyarrhythmias.
    Interian A; Zaman L; Velez-Robinson E; Kozlovskis P; Castellanos A; Myerburg RJ
    J Am Coll Cardiol; 1991 Jun; 17(7):1581-6. PubMed ID: 2033190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Electrophysiologic effects of enoximone].
    Brembilla-Perrot B; Beurrier D; Bock F; Danglas P
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():69-74. PubMed ID: 2147838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias.
    Nademanee K; Feld G; Hendrickson J; Singh PN; Singh BN
    Circulation; 1985 Sep; 72(3):555-64. PubMed ID: 4017207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Idiopathic monomorphic ventricular tachycardia: clinical outcome, electrophysiologic characteristics and long-term results of catheter ablation.
    Tsai CF; Chen SA; Tai CT; Chiang CE; Lee SH; Wen ZC; Huang JL; Ding YA; Chang MS
    Int J Cardiol; 1997 Nov; 62(2):143-50. PubMed ID: 9431865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of incremental doses of procainamide in patients with sustained uniform ventricular tachycardia.
    Grimm W; Cho JG; Marchlinski FE
    J Cardiovasc Electrophysiol; 1994 Apr; 5(4):313-22. PubMed ID: 8019707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol.
    Leite LR; Fenelon G; Simoes A; Silva GG; Friedman PA; de Paola AA
    J Cardiovasc Electrophysiol; 2003 Jun; 14(6):567-73. PubMed ID: 12875414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.